---
search:
  boost: .9
---

# Dermatologic Agents - Oral Acne Products 

[Criteria Document](https://mygainwell-my.sharepoint.com/:w:/g/personal/kaelyn_dobbins_gainwelltechnologies_com/Edpg-Td84zhNpCtyvy5SThUBG_ON7ynRnKWfnEa2EXXqNw?e=s8rq1V){:target="_blank" rel="noopener}

## Criteria { data-search-exclude }

|||
| ---------- | ---------------------------------------------------------------------------------- |
| Criteria 1 | P agents with PA (Accutane, Amnesteem, Claravis, Isotretinoin, Myorisan, Zenatane) |
| Criteria 2 | NP agents (Absorica, Absorica LD)                                                  |

   

<table>
<thead>
<tr class="header">
<th><strong>Criteria Title</strong></th>
<th>Dermatologic Agents: Oral Acne Products</th>
<th></th>
<th></th>
</tr>
</thead>
<tbody>
<tr class="odd">
<td><strong>Criteria Subtitle</strong></td>
<td>Preferred Products</td>
<td></td>
<td></td>
</tr>
<tr class="even">
<td><strong>Approval Level</strong></td>
<td>GCNSeqNo</td>
<td></td>
<td></td>
</tr>
<tr class="odd">
<td><p><strong>Products</strong></p>
<table>
<thead>
<tr class="header">
<th>Preferred</th>
<th>X</th>
</tr>
</thead>
<tbody>
<tr class="odd">
<td>Non-Preferred</td>
<td></td>
</tr>
<tr class="even">
<td>Brand</td>
<td></td>
</tr>
<tr class="odd">
<td>Generic</td>
<td></td>
</tr>
<tr class="even">
<td>Other</td>
<td></td>
</tr>
</tbody>
</table></td>
<td>Drug Name</td>
<td>Corresponding Code (s)</td>
<td>Type of Code (GCNSeqNo, HICL, NDC)</td>
</tr>
<tr class="even">
<td></td>
<td>ACCUTANE</td>
<td>036045</td>
<td>GCNSeqNo</td>
</tr>
<tr class="odd">
<td></td>
<td>ACCUTANE</td>
<td>036046</td>
<td>GCNSeqNo</td>
</tr>
<tr class="even">
<td></td>
<td>ACCUTANE</td>
<td>036047</td>
<td>GCNSeqNo</td>
</tr>
<tr class="odd">
<td></td>
<td>ACCUTANE</td>
<td>053055</td>
<td>GCNSeqNo</td>
</tr>
<tr class="even">
<td></td>
<td>AMNESTEEM</td>
<td>036045</td>
<td>GCNSeqNo</td>
</tr>
<tr class="odd">
<td></td>
<td>AMNESTEEM</td>
<td>036046</td>
<td>GCNSeqNo</td>
</tr>
<tr class="even">
<td></td>
<td>AMNESTEEM</td>
<td>036047</td>
<td>GCNSeqNo</td>
</tr>
<tr class="odd">
<td></td>
<td>CLARAVIS</td>
<td>036045</td>
<td>GCNSeqNo</td>
</tr>
<tr class="even">
<td></td>
<td>CLARAVIS</td>
<td>036046</td>
<td>GCNSeqNo</td>
</tr>
<tr class="odd">
<td></td>
<td>CLARAVIS</td>
<td>036047</td>
<td>GCNSeqNo</td>
</tr>
<tr class="even">
<td></td>
<td>CLARAVIS</td>
<td>053055</td>
<td>GCNSeqNo</td>
</tr>
<tr class="odd">
<td></td>
<td>ISOTRETINOIN</td>
<td>036045</td>
<td>GCNSeqNo</td>
</tr>
<tr class="even">
<td></td>
<td>ISOTRETINOIN</td>
<td>036046</td>
<td>GCNSeqNo</td>
</tr>
<tr class="odd">
<td></td>
<td>ISOTRETINOIN</td>
<td>036047</td>
<td>GCNSeqNo</td>
</tr>
<tr class="even">
<td></td>
<td>ISOTRETINOIN</td>
<td>053055</td>
<td>GCNSeqNo</td>
</tr>
<tr class="odd">
<td></td>
<td>ISOTRETINOIN</td>
<td>072730</td>
<td>GCNSeqNo</td>
</tr>
<tr class="even">
<td></td>
<td>ISOTRETINOIN</td>
<td>072731</td>
<td>GCNSeqNo</td>
</tr>
<tr class="odd">
<td></td>
<td>MYORISAN</td>
<td>036045</td>
<td>GCNSeqNo</td>
</tr>
<tr class="even">
<td></td>
<td>MYORISAN</td>
<td>036046</td>
<td>GCNSeqNo</td>
</tr>
<tr class="odd">
<td></td>
<td>MYORISAN</td>
<td>063047</td>
<td>GCNSeqNo</td>
</tr>
<tr class="even">
<td></td>
<td>MYORISAN</td>
<td>053055</td>
<td>GCNSeqNo</td>
</tr>
<tr class="odd">
<td></td>
<td>ZENATANE</td>
<td>036045</td>
<td>GCNSeqNo</td>
</tr>
<tr class="even">
<td></td>
<td>ZENATANE</td>
<td>036046</td>
<td>GCNSeqNo</td>
</tr>
<tr class="odd">
<td></td>
<td>ZENATANE</td>
<td>036047</td>
<td>GCNSeqNo</td>
</tr>
<tr class="even">
<td></td>
<td>ZENATANE</td>
<td>053055</td>
<td>GCNSeqNo</td>
</tr>
</tbody>
</table>

<table>
<thead>
<tr class="header">
<th><strong>Sequence Number</strong>  </th>
<th><strong>Question ID</strong>  </th>
<th><strong>Default Next Question ID</strong>  </th>
<th><strong>Question Type</strong>  </th>
<th><strong>Question Text</strong>  </th>
<th><strong>Choice Text</strong>  </th>
<th><strong>Next Question ID</strong>  </th>
</tr>
</thead>
<tbody>
<tr class="odd">
<td>1  </td>
<td>1000</td>
<td></td>
<td>Select </td>
<td><p>Is the patient new to therapy (initial authorization request) or continuing therapy (re-authorization request)?  </p>
<p>  </p></td>
<td>New Start (initial authorization request)</td>
<td>1001</td>
</tr>
<tr class="even">
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td>Continuation (re-authorization request)  </td>
<td>1233</td>
</tr>
<tr class="odd">
<td>2  </td>
<td>1001  </td>
<td>  </td>
<td>Select  </td>
<td>Is this request being prescribed in accordance with Food and Drug Administration (FDA) approved labeling?   </td>
<td>Y  </td>
<td>1002 </td>
</tr>
<tr class="even">
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td>N  </td>
<td>1235 </td>
</tr>
<tr class="odd">
<td>3  </td>
<td>1002  </td>
<td>  </td>
<td>Select  </td>
<td>Is the patient registered and does the patient meet all of the requirements of the iPLEDGE program? </td>
<td>Y  </td>
<td>1003 </td>
</tr>
<tr class="even">
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td>N  </td>
<td>1235 </td>
</tr>
<tr class="odd">
<td>4  </td>
<td>1003  </td>
<td>  </td>
<td>Select and Free Text </td>
<td><p>Has the patient had an inadequate clinical response of at least <span class="underline">90 days</span> with at least <span class="underline">one preferred</span> topical for acne? </p>
<p>If yes, please submit the medication trials and dates.</p></td>
<td>Y  </td>
<td>1004 </td>
</tr>
<tr class="even">
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td>N  </td>
<td>1235 </td>
</tr>
<tr class="odd">
<td>5  </td>
<td>1004  </td>
<td></td>
<td>Select and Free Text </td>
<td><p>Has the patient had an inadequate clinical response of at least <span class="underline">90 days</span> with at least <span class="underline">one preferred</span> oral antibiotic for acne? </p>
<p>If yes, please submit the medication trials and dates.</p></td>
<td>Y  </td>
<td>1005</td>
</tr>
<tr class="even">
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td>N  </td>
<td>1235 </td>
</tr>
<tr class="odd">
<td>6</td>
<td>1005</td>
<td>  </td>
<td>Select  </td>
<td>Has the patient been absent oral tretinoin in the past 56 days? </td>
<td>Y  </td>
<td>END (Pending Manual Review)</td>
</tr>
<tr class="even">
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td>N  </td>
<td>1235 </td>
</tr>
<tr class="odd">
<td>7</td>
<td>1233</td>
<td></td>
<td><p>Select and Free Text </p>
<p>   </p></td>
<td>Has the provider submitted documentation of the patient’s clinical response to treatment and ongoing safety monitoring?</td>
<td>Y  </td>
<td>1234</td>
</tr>
<tr class="even">
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td>N  </td>
<td>1235</td>
</tr>
<tr class="odd">
<td>8</td>
<td>1234</td>
<td></td>
<td>Select</td>
<td>Has the patient been absent oral tretinoin in the past 56 days?</td>
<td>Y</td>
<td>END (Pending Manual Review)</td>
</tr>
<tr class="even">
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td>N</td>
<td>1235</td>
</tr>
<tr class="odd">
<td>9</td>
<td>1235  </td>
<td>  </td>
<td>Free Text  </td>
<td>Please provide the rationale for the medication being requested.   </td>
<td> END (Pending Manual Review) </td>
<td></td>
</tr>
</tbody>
</table>

LENGTH OF AUTHORIZATIONS: 150 days  

 

| **Last Approved ** | 4/13/2023 |
| ------------------ | --------- |
| **Other**          |           |

 

<table>
<thead>
<tr class="header">
<th><strong>Criteria Title</strong></th>
<th>Dermatologic Agents: Oral Acne Products</th>
<th></th>
<th></th>
</tr>
</thead>
<tbody>
<tr class="odd">
<td><strong>Criteria Subtitle</strong></td>
<td>Non-Preferred Products</td>
<td></td>
<td></td>
</tr>
<tr class="even">
<td><strong>Approval Level</strong></td>
<td>GCNSeqNo</td>
<td></td>
<td></td>
</tr>
<tr class="odd">
<td><p><strong>Products</strong></p>
<table>
<thead>
<tr class="header">
<th>Preferred</th>
<th></th>
</tr>
</thead>
<tbody>
<tr class="odd">
<td>Non-Preferred</td>
<td>X</td>
</tr>
<tr class="even">
<td>Brand</td>
<td></td>
</tr>
<tr class="odd">
<td>Generic</td>
<td></td>
</tr>
<tr class="even">
<td>Other</td>
<td></td>
</tr>
</tbody>
</table></td>
<td>Drug Name</td>
<td>Corresponding Code (s)</td>
<td>Type of Code (GCNSeqNo, HICL, NDC)</td>
</tr>
<tr class="even">
<td></td>
<td>ABSORBICA</td>
<td>036045</td>
<td>GCNSeqNo</td>
</tr>
<tr class="odd">
<td></td>
<td>ABSORBICA</td>
<td>036046</td>
<td>GCNSeqNo</td>
</tr>
<tr class="even">
<td></td>
<td>ABSORBICA</td>
<td>036047</td>
<td>GCNSeqNo</td>
</tr>
<tr class="odd">
<td></td>
<td>ABSORBICA</td>
<td>053055</td>
<td>GCNSeqNo</td>
</tr>
<tr class="even">
<td></td>
<td>ABSORBICA</td>
<td>072730</td>
<td>GCNSeqNo</td>
</tr>
<tr class="odd">
<td></td>
<td>ABSORBICA</td>
<td>072731</td>
<td>GCNSeqNo</td>
</tr>
<tr class="even">
<td></td>
<td>ABSORBICA LD</td>
<td>080449</td>
<td>GCNSeqNo</td>
</tr>
<tr class="odd">
<td></td>
<td>ABSORBICA LD</td>
<td>080450</td>
<td>GCNSeqNo</td>
</tr>
<tr class="even">
<td></td>
<td>ABSORBICA LD</td>
<td>080452</td>
<td>GCNSeqNo</td>
</tr>
<tr class="odd">
<td></td>
<td>ABSORBICA LD</td>
<td>080454</td>
<td>GCNSeqNo</td>
</tr>
</tbody>
</table>

<table>
<thead>
<tr class="header">
<th><strong>Sequence Number</strong>  </th>
<th><strong>Question ID</strong>  </th>
<th><strong>Default Next Question ID</strong>  </th>
<th><strong>Question Type</strong>  </th>
<th><strong>Question Text</strong>  </th>
<th><strong>Choice Text</strong>  </th>
<th><strong>Next Question ID</strong></th>
<th></th>
</tr>
</thead>
<tbody>
<tr class="odd">
<td>1  </td>
<td>1000</td>
<td></td>
<td>Select </td>
<td><p>Is the patient new to therapy (initial authorization request) or continuing therapy (re-authorization request)?  </p>
<p>  </p></td>
<td>New Start (initial authorization request)</td>
<td>1001</td>
<td></td>
</tr>
<tr class="even">
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td>Continuation (re-authorization request)  </td>
<td>1233</td>
<td></td>
</tr>
<tr class="odd">
<td>2  </td>
<td>1001  </td>
<td>  </td>
<td>Select  </td>
<td>Is this request being prescribed in accordance with Food and Drug Administration (FDA) approved labeling?   </td>
<td>Y  </td>
<td>1002</td>
<td></td>
</tr>
<tr class="even">
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td>N  </td>
<td>1235</td>
<td></td>
</tr>
<tr class="odd">
<td>3  </td>
<td>1002  </td>
<td>  </td>
<td>Select  </td>
<td>Is the patient registered and does the patient meet all of the requirements of the iPLEDGE program? </td>
<td>Y  </td>
<td>1003</td>
<td></td>
</tr>
<tr class="even">
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td>N  </td>
<td>1235</td>
<td></td>
</tr>
<tr class="odd">
<td>4</td>
<td>1003</td>
<td></td>
<td>Select and Free Text</td>
<td><p>Has the patient had an inadequate clinical response of at least <span class="underline">90 days</span> with at least <span class="underline">one preferred</span> topical for acne? </p>
<p>If yes, please submit the medication trials and dates.</p></td>
<td>Y</td>
<td>1004</td>
<td></td>
</tr>
<tr class="even">
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td>N</td>
<td>1235</td>
<td></td>
</tr>
<tr class="odd">
<td>5</td>
<td>1004</td>
<td></td>
<td>Select and Free Text</td>
<td><p>Has the patient had an inadequate clinical response of at least <span class="underline">90 days</span> with at least <span class="underline">one preferred</span> oral antibiotic for acne? </p>
<p>If yes, please submit the medication trials and dates.</p></td>
<td>Y</td>
<td>1005</td>
<td></td>
</tr>
<tr class="even">
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td>N</td>
<td>1235</td>
<td></td>
</tr>
<tr class="odd">
<td>6</td>
<td>1005</td>
<td>  </td>
<td>Select and Free Text </td>
<td><p>Has the patient had an inadequate clinical response of at least <span class="underline">90 days</span> with at least <span class="underline">two preferred</span> drugs? </p>
<p>If yes, please submit the medication trials and dates.</p></td>
<td>Y  </td>
<td>1007</td>
<td></td>
</tr>
<tr class="even">
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td>N  </td>
<td>1006</td>
<td></td>
</tr>
<tr class="odd">
<td>7</td>
<td>1006</td>
<td></td>
<td>Select and Free Text</td>
<td><p>Has the provider submitted documentation of medical necessity beyond convenience for why the patient cannot be changed to a preferred drug (i.e., allergies, drug-drug interactions, contraindications, or intolerances)?</p>
<p>If yes, please submit the medication name and reason for inability to use. </p></td>
<td>Y   </td>
<td>1007</td>
<td></td>
</tr>
<tr class="even">
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td>N   </td>
<td>1236</td>
<td></td>
</tr>
<tr class="odd">
<td>8</td>
<td>1007</td>
<td>  </td>
<td>Select  </td>
<td>Has the patient been absent oral tretinoin in the past 56 days? </td>
<td>Y  </td>
<td>1008</td>
<td></td>
</tr>
<tr class="even">
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td>N  </td>
<td>1235</td>
<td></td>
</tr>
<tr class="odd">
<td>9</td>
<td>1008</td>
<td></td>
<td>Select</td>
<td><p>Is the request for any of the following:</p>
<p>1) a nonsolid oral dosage formulation</p>
<p>2) a non-preferred extended release formulation</p>
<p>3) a non-preferred brand name that has a preferred generic product</p></td>
<td>Y</td>
<td>1009</td>
<td></td>
</tr>
<tr class="even">
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td>N</td>
<td>END (Pending Manual Review)</td>
<td></td>
</tr>
<tr class="odd">
<td>10</td>
<td>1009</td>
<td></td>
<td>Select and Free Text</td>
<td>Has the provider submitted documentation of medical necessity for the requested product (i.e. medical reasons for why the patient cannot be changed to a solid oral dosage formulation, inadequate clinical response with a product’s immediate release formulation, or inadequate clinical response or allergy of two or more generic labelers)?</td>
<td>Y</td>
<td>END (Pending Manual Review)</td>
<td></td>
</tr>
<tr class="even">
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td>N</td>
<td>1235</td>
<td></td>
</tr>
<tr class="odd">
<td>11</td>
<td>1233</td>
<td></td>
<td><p>Select and Free Text </p>
<p>   </p></td>
<td>Has the provider submitted documentation of the patient’s clinical response to treatment and ongoing safety monitoring?</td>
<td>Y  </td>
<td>1234</td>
<td></td>
</tr>
<tr class="even">
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td>N  </td>
<td>1235</td>
<td></td>
</tr>
<tr class="odd">
<td>12</td>
<td>1234</td>
<td></td>
<td>Select</td>
<td>Has the patient been absent oral tretinoin in the past 56 days?</td>
<td>Y</td>
<td>END (Pending Manual Review)</td>
<td></td>
</tr>
<tr class="even">
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td>N</td>
<td>1235</td>
<td></td>
</tr>
<tr class="odd">
<td>13</td>
<td>1235  </td>
<td>  </td>
<td>Free Text  </td>
<td>Please provide the rationale for the medication being requested.   </td>
<td>END (Pending Manual Review) </td>
<td></td>
<td></td>
</tr>
<tr class="even">
<td>14</td>
<td>1236</td>
<td></td>
<td>Free Text</td>
<td>Please explain the reason(s) why the patient is unable to use medications not requiring prior approval.</td>
<td>END (Pending Manual Review)</td>
<td></td>
<td></td>
</tr>
</tbody>
</table>

LENGTH OF AUTHORIZATIONS: 150 days 

| **Last Approved ** | 4/13/2023 |
| ------------------ | --------- |
| **Other**          |           |
